Long-term efficacy and safety of the special extract ERr 731 of Rheum rhaponticum in perimenopausal women with menopausal symptoms

Menopause

Volumn 16, Issue 1, 2009, Pages 117-131

  Hasper, Ilona ^a   Ventskovskiy, Boris M ^b   Rettenberger, Reinhard ^c   Heger, Peter W ^a   Riley, David S ^d   Kaszkin Bettag, Marietta ^a  

^a Health Research Services Ltd   (Germany)

^b BOGOMOLETS NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^c Carl Mueller Apotheker GmbH U Co KG   (Germany)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Herbal; Hot flushes; Menopausal; Menopause Rating Scale; Perimenopause; Rhapontic rhubarb

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ERR 731; GAMMA GLUTAMYLTRANSFERASE; LIPID; PLACEBO; PLANT EXTRACT; RHEUM RHAPONTICUM EXTRACT; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; BREAST TENDERNESS; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENTERIC COATED TABLET; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMATOLOGY; HOT FLUSH; HUMAN; INTERCOSTAL NEURALGIA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENOPAUSAL SYNDROME; MENSTRUATION; MULTICENTER STUDY; NEURALGIA; PAPANICOLAOU TEST; PATIENT SATISFACTION; PULSE RATE; RADICULAR PAIN; RHEUM RHAPONTICUM; RHUBARB; SIDE EFFECT; TREATMENT OUTCOME; VAGINA SMEAR; WEIGHT GAIN; BIOPSY; BLOOD; CONTROLLED CLINICAL TRIAL; LIVER FUNCTION TEST; MENOPAUSE; MIDDLE AGED; PATHOLOGY; PHASE 3 CLINICAL TRIAL; PHYTOTHERAPY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

BIOPSY; BLOOD PRESSURE; BODY MASS INDEX; DOUBLE-BLIND METHOD; ENDOMETRIUM; FEMALE; GONADAL STEROID HORMONES; HOT FLASHES; HUMANS; LIVER FUNCTION TESTS; MENOPAUSE; MIDDLE AGED; PATIENT SATISFACTION; PHYTOTHERAPY; PLACEBOS; PLANT EXTRACTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 64049099339     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181806446     Document Type: Article

References (27)

1. The North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007;14:168-182.
2. Grady D, Barrett-Connor E. Postmenopausal hormone therapy. BMJ 2007;334:860-861.
3. Panay N, Ylikorkala O, Archer DF, Gut R, Lang E. Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief. Climacteric 2007;10:120-131.
4. EMEA. Recommendation on the need for revision of the CPMP points to consider on hormone replacement therapy. CHMP/EWP/021/ 097, Rev. 1, 2005.
5. Heger M, Ventskovskiy BM, Borzenko I, et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12-week randomized, double-blind, placebo-controlled trial. Menopause 2006;13:744-759.
6. Kaszkin-Bettag M, Ventskovskiy BM, Kravchenko A, et al. The special extract ERr 731 of the roots of Rheum rhaponticum decreases anxiety and improves health state and general well-being in perimenopausal women. Menopause 2007;14:270-283.
7. Hauser GA, Schneider HPG, Rosemeier PJ, et al. Die Selbstbeurteilungs- Skala für klimakterische Beschwerden (Menopause Rating Scale II). J Menopause 1999;4:13-17.
8. Potthoff P, Heinemann LA, Schneider HP, Rosemeier HP, Hauser GA. The Menopause Rating Scale (MRS II): methodological standardization in the German population. Zentralbl Gynakol 2000;122:280-286.
9. Notelovitz M, Lenihan JP, McDermott M, Kerber IJ, Nanavati N, Arce J-C. Initial 17β-estradiol dose for treating vasomotor symptoms. Obstet Gynecol 2000;95:726-731.
10. Heger M, Riley DS, Haidvogl M. International integrate primary care outcomes study (IIPCOS-2): an international research project of homeopathy in primary care. Br Homepath J 2000;89(suppl 1):S10-S13.
11. Kaszkin-Bettag M, Beck S, Richardson A, Heger PW, Beer A-M. Efficacy of the special extract ERr 731® from rhapontic rhubarb for menopausal complaints: a 6-month open observational study. Altern Ther Health Med; in press.
12. Heinemann LA, Potthoff P, Schneider HP. International versions of the Menopause Rating Scale. Health Qual Life Outcomes 2003;1:28.
13. Wober J, Moller F, Richter T, et al. Activation of estrogen receptor-β by a special extract of Rheum rhaponticum (ERr 731®), its aglycones and structurally related compounds. J Steroid Biochem Mol Biol 2007;107:191-201.
14. Riley DS, Vollmer G, Kaszkin-Bettag M. Mechanisms of action of the Rheum rhaponticum (Siberian rhubarb) special extract ERr 731®. Presented at the 8th Meeting of The North American Menopause Society October 3-6, 2007, Dallas, TX, abstract no. 8.
15. Kaszkin-Bettag M, Richardson A, Rettenberger R, Heger PW. Long-term toxicity studies in dogs support the safety of the special extract ERr 731 from the roots of Rheum rhaponticum. Food Chem Toxicol 2008;46;1608-1618.
16. Randolph JF Jr, Sowers M, Bondarenko IV, Harlow SD, Luborsky JL, Little RJ. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. J Clin Endocrinol Metab 2004;89:1555-1561.
17. Johnson MS, Wolbers WB, Noble J, Fennell M, Mitchell R. Effect of tyrosine kinase inhibitors on luteinizing hormone-releasing hormone (LHRH)-induced gonadotropin release from the anterior pituitary. Mol Cell Endocrinol 1995;109:69-75.
18. Bowe J, Feng Li X, Kinsey-Jones J, et al. The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy induced rise in skin temperature in an animal model of menopausal hot flushes. J Endocrinol 2006;191:399-405.
19. Möller F, Zierau M, Jandausch A, Rettenberger R, Kaszkin-Bettag M, Vollmer G. Subtype-specific activation of estrogen receptors by a special extract of Rheum rhaponticum (ERr 731®), its aglycones and structurally related compounds in U2OS human osteosarcoma cells. Phytomedicine 2007;14:716-726.
20. Lasley BL, Santoro N, Randolf JF, et al. The relationship of circulating dehydroepiandrosterone, testosterone, and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002;87:3760-3767.
21. Wang Y, Lee KW, Chan FL, Chen S, Leung LK. The red wine polyphenol resveratrol displays bilevel inhibition on aromatase in breast cancer cells. Toxicol Sci 2006;92:71-77.
22. Schover LR. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk? Fertil Steril 2008;90:129-140.
23. Lindberg MK, Movérare S, Skrtic S, et al. Estrogen receptor (ER)-β reduces ER-α-regulated gene transcription, supporting a "ying yang" relationship between ER-α and ER-β in mice. Mol Endocrinol 2003;17:203-208.
24. Lazennec G. Estrogen receptor β, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett 2006;231:151-157.
25. Speirs V, Walker RA. New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast. J Pathol 2007;211:499-506.
26. Harris HA. Estrogen receptor-β: recent lessons from in vivo studies. Mol Endocrinol 2007;21:1-13.
27. Gustafsson JA. ERβ scientific visions translate to clinical uses. Climacteric 2006;9:156-160.